- $2.46bn
- $2.06bn
- $549.59m
- 90
- 48
- 85
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 319 | 359 | 425 | 458 | 550 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 287 | 304 | 354 | 318 | 328 |
Operating Profit | 32.3 | 55.2 | 71.2 | 139 | 222 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.9 | 31.3 | 57.6 | 118 | 235 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15 | 37.9 | 42.2 | 92.1 | 211 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.9 | 44.8 | 55.3 | 93.7 | 214 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.9 | 44.8 | 55.3 | 93.7 | 214 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.347 | 1.51 | 2.42 | 3.45 | 7.7 |
Dividends per Share |